Glenmede Trust Co. NA boosted its position in Amdocs Limited (NASDAQ:DOX – Free Report) by 18.3% during the 3rd quarter, Holdings Channel.com reports. The firm owned 157,780 shares of the technology company’s stock after purchasing an additional 24,442 shares during the period. Glenmede Trust Co. NA’s holdings in Amdocs were worth $13,803,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also bought and sold shares of the company. Private Trust Co. NA raised its position in shares of Amdocs by 62.9% in the third quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock valued at $27,000 after purchasing an additional 117 shares during the period. Brooklyn Investment Group bought a new stake in Amdocs during the 3rd quarter valued at $28,000. Catalyst Capital Advisors LLC purchased a new stake in shares of Amdocs during the third quarter worth $55,000. GAMMA Investing LLC boosted its holdings in shares of Amdocs by 115.1% in the third quarter. GAMMA Investing LLC now owns 800 shares of the technology company’s stock worth $70,000 after acquiring an additional 428 shares during the period. Finally, Meeder Asset Management Inc. purchased a new position in shares of Amdocs in the third quarter valued at $77,000. 92.02% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of analysts recently issued reports on DOX shares. Oppenheimer increased their price objective on Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. StockNews.com lowered shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 14th. Barclays decreased their target price on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a report on Thursday, November 14th. Finally, Stifel Nicolaus assumed coverage on shares of Amdocs in a report on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 price target for the company. One analyst has rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Amdocs has an average rating of “Moderate Buy” and an average price target of $101.83.
Amdocs Stock Down 0.2 %
DOX stock opened at $87.18 on Friday. Amdocs Limited has a 1-year low of $74.41 and a 1-year high of $94.04. The stock has a market cap of $10.25 billion, a price-to-earnings ratio of 20.56, a price-to-earnings-growth ratio of 1.46 and a beta of 0.74. The company has a current ratio of 1.20, a quick ratio of 1.24 and a debt-to-equity ratio of 0.21. The company’s 50 day moving average is $88.07 and its 200 day moving average is $84.05.
Amdocs Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.479 per share. This represents a $1.92 annualized dividend and a dividend yield of 2.20%. The ex-dividend date of this dividend is Tuesday, December 31st. Amdocs’s dividend payout ratio (DPR) is currently 45.28%.
Amdocs Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Read More
- Five stocks we like better than Amdocs
- Why Invest in High-Yield Dividend Stocks?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Profitably Trade Stocks at 52-Week Highs
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.